Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2026-03-05 @ 12:18 AM
Study NCT ID:
NCT02243293
Status:
COMPLETED
Last Update Posted:
2021-07-30
First Post:
2014-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-19
Start Date Type:
None
Primary Completion Date:
2016-10-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-04
First Submit QC Date:
None
Study First Post Date:
2014-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-31
Results First Submit QC Date:
None
Results First Post Date:
2017-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-02-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-07-09
Last Update Post Date:
2021-07-30
Last Update Post Date Type:
ACTUAL